Tata Elxsi vs Jabil Healthcare: full comparison for 2026
Quick verdict
Tata Elxsi (3.9/5) edges ahead of Jabil Healthcare (3.8/5) overall. Tata Elxsi is the better choice for large medtech firms offshoring sustaining engineering. Jabil Healthcare is the stronger option for global production capacity for cleared devices. The right choice depends on your project size, budget, and required tech stack.
Tata Elxsi vs Jabil Healthcare: head-to-head summary
| Criterion | Tata Elxsi | Jabil Healthcare |
|---|---|---|
| Founded | 1989 | 1966 |
| HQ | Bengaluru, India | St. Petersburg, FL, USA |
| Team size | 13,000+ | ~20,000 (healthcare) |
| Rating | 3.9 / 5 | 3.8 / 5 |
| Primary differentiator | Offshore scale for verification, documentation and sustaining work on existing device portfolios | Global scale, supply chain and FDA-registered production for established medical device brands |
| Pricing model | Time and materials, dedicated team, fixed project | Manufacturing supply agreement, NPI contract |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Embedded C/C++, Embedded Linux, Test automation | Injection molding, Automated assembly, PCB assembly |
| Industries served | Surgical & therapeutic devices, Diagnostics & lab devices, Digital health, Automotive | Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health |
Tata Elxsi vs Jabil Healthcare: overview
Tata Elxsi
Tata Elxsi is a Tata Group engineering and design company founded in 1989 and headquartered in Bengaluru, with more than 13,000 employees across automotive, media and healthcare. Its medical device practice covers hardware, firmware, mechanical engineering, verification and validation and lifecycle management under an ISO 13485:2016 compliant QMS, and it offers pre-submission support for 510(k) and PMA filings. In 2026 it opened an offshore development center for Terumo in Pune and launched AnaTel, an AI tool for preparing regulatory documents.
Jabil Healthcare
Jabil Healthcare was formed in 2020 when Jabil combined its Nypro business with its orthopedics, spine and trauma units. At launch it had nearly 20,000 employees and more than 35 sites, and its factories producing finished medical devices are FDA registered. It covers minimally invasive devices, surgical robotics, complex catheters, diabetes care and consumer health, and the acquisition of CDMO Pii extended it into drug development and aseptic fill-finish. Jabil reported $8.3 billion in company-wide revenue for its second fiscal quarter of 2026.
Services and capabilities: Tata Elxsi vs Jabil Healthcare
| Capability | Tata Elxsi | Jabil Healthcare |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✓ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Tata Elxsi vs Jabil Healthcare
| Framework / platform | Tata Elxsi | Jabil Healthcare |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | ✓ | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | ✓ | N/A |
| IEC 62304 | ✓ | N/A |
| ISO 14971 | ✓ | N/A |
| ISO 13485 QMS | N/A | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Tata Elxsi vs Jabil Healthcare
| Criterion | Tata Elxsi | Jabil Healthcare |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Dedicated team, Fixed project, Time & materials | Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Tata Elxsi vs Jabil Healthcare
| Dimension | Tata Elxsi | Jabil Healthcare |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Surgical & therapeutic devices, Diagnostics & lab devices, Digital health | Surgical & robotics, Drug delivery, Wearables & remote monitoring |
| Best use cases | Sustaining engineering for a portfolio of cleared devices, EU MDR technical file remediation | Scaling production of a cleared diabetes device, Global manufacturing of a surgical robotics subsystem |
| Typical project type | Dedicated team | Manufacturing contract |
Tata Elxsi vs Jabil Healthcare: pros and cons
| Tata Elxsi | |
|---|---|
| + | Can staff large verification, documentation and sustaining teams |
| + | Offshore development centers for major medtech clients such as Terumo |
| + | Supports 510(k) and PMA preparation |
| + | Lower cost per engineer than Western firms |
| - | Large generalist where healthcare competes with automotive and media for attention |
| - | Better suited to established portfolios than to early-stage invention |
| - | Offshore delivery needs strong client-side technical ownership |
| Jabil Healthcare | |
|---|---|
| + | One of the largest healthcare manufacturing networks in the world |
| + | FDA-registered sites for finished devices |
| + | Strong supply chain management during component shortages |
| + | Covers drug delivery through the Pii acquisition |
| - | Built for production volume; early design and invention are outside its main business |
| - | Small companies may struggle to get attention |
| - | Engineering support is tied to manufacturing programs |
Who should choose Tata Elxsi?
A typical fit: sustaining engineering for a portfolio of cleared devices.
Offshore scale for verification, documentation and sustaining work on existing device portfolios. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Digital health, Automotive.
Who should choose Jabil Healthcare?
A typical fit: scaling production of a cleared diabetes device.
Global scale, supply chain and FDA-registered production for established medical device brands. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & robotics, Drug delivery, Wearables & remote monitoring, Consumer health.
Decision matrix: Tata Elxsi vs Jabil Healthcare
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Tata Elxsi |
| You need a large dedicated team for an ongoing programme | Tata Elxsi |
| Your budget is at the lower end | Compare: Tata Elxsi (Not disclosed) vs Jabil Healthcare (Not disclosed) |
| You need specialist depth in a specific vertical | Tata Elxsi |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Tata Elxsi vs Jabil Healthcare
| Use case | Tata Elxsi fit | Jabil Healthcare fit | Winner |
|---|---|---|---|
| Sustaining engineering for a portfolio of cleared devices | Strong | Limited | Tata Elxsi |
| EU MDR technical file remediation | Strong | Limited | Tata Elxsi |
| Scaling production of a cleared diabetes device | Limited | Strong | Jabil Healthcare |
| Global manufacturing of a surgical robotics subsystem | Limited | Strong | Jabil Healthcare |
Verdict: Tata Elxsi vs Jabil Healthcare
Tata Elxsi (3.9/5) is the stronger overall choice for most Medical Device Development projects. Offshore scale for verification, documentation and sustaining work on existing device portfolios.
Jabil Healthcare (3.8/5) is worth a look if you need global manufacturing of a surgical robotics subsystem. If your situation matches that, Jabil Healthcare is a competitive option.
Related comparisons
Tata Elxsi vs Jabil Healthcare FAQ
Is Tata Elxsi better than Jabil Healthcare?
Tata Elxsi (3.9/5) scores higher overall, but "better" depends on your use case. Tata Elxsi's strongest advantage: can staff large verification, documentation and sustaining teams. Jabil Healthcare's strongest advantage: one of the largest healthcare manufacturing networks in the world.
How do Tata Elxsi and Jabil Healthcare differ in pricing?
Tata Elxsi uses time and materials, dedicated team, fixed project pricing. Jabil Healthcare uses manufacturing supply agreement, npi contract pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Tata Elxsi or Jabil Healthcare?
Jabil Healthcare is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Tata Elxsi and Jabil Healthcare?
Tata Elxsi's primary differentiator is: offshore scale for verification, documentation and sustaining work on existing device portfolios. Jabil Healthcare's primary differentiator is: global scale, supply chain and FDA-registered production for established medical device brands. They also differ in team size (13,000+ vs ~20,000 (healthcare)), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Surgical & therapeutic devices, Diagnostics & lab devices vs Surgical & robotics, Drug delivery).
Verify all details directly with each company before making a decision.